Literature DB >> 31084491

Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: A Clinical and Radiological 2- to 8-Year Follow-up Study.

Lizzy Weigelt1, Rebecca Hartmann1, Christian Pfirrmann2, Norman Espinosa3, Stephan H Wirth1.   

Abstract

BACKGROUND: Autologous matrix-induced chondrogenesis (AMIC) has become an interesting treatment option for osteochondral lesions of the talus (OLTs) with promising clinical short- to midterm results.
PURPOSE: To investigate the clinical and radiological outcome of the AMIC procedure for OLTs, extending the follow-up to 8 years. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: Thirty-three patients (mean age, 35.1 years; body mass index, 26.8) with osteochondral lesions of the medial talar dome were retrospectively evaluated after open AMIC repair at a mean follow-up of 4.7 years (range, 2.3-8.0 years). Patients requiring additional surgical procedures were excluded. All OLTs (mean size, 0.9 cm2; range, 0.4-2.3 cm2) were approached through a medial malleolar osteotomy, and 28 patients received subchondral autologous bone grafting. Data analysis included the visual analog scale for pain, the American Orthopaedic Foot and Ankle Society score for ankle function, the Tegner score for sports activity, and the MOCART (magnetic resonance observation of cartilage repair tissue) scoring system for repair cartilage and subchondral bone evaluation.
RESULTS: Mean ± SD visual analog scale score improved significantly from 6.4 ± 1.9 preoperatively to 1.4 ± 2.0 at latest follow-up ( P < .001). The mean American Orthopaedic Foot and Ankle Society score was 93.0 ± 7.5 (range, 75-100). The Tegner score improved significantly from 3.5 ± 1.8 preoperatively to 5.2 ± 1.7 at latest follow-up ( P < .001), and 79% returned to their previous sports levels. The MOCART score averaged 60.6 ± 21.2 (range, 0-100). Complete filling of the defect was seen in 88% of cases, but 52% showed hypertrophy of the cartilage layer. All but 1 patient showed persistent subchondral bone edema. The patient's age and body mass index, the size of the osteochondral lesion, and the MOCART score did not show significant correlation with the clinical outcome. There were no cases of revision surgery for failed AMIC. Fifty-eight percent underwent reoperation, mainly for symptomatic hardware after malleolar osteotomy.
CONCLUSION: AMIC for osteochondral talar lesions led to significant pain reduction, recovery of ankle function, and successful return to sport. The MOCART score did not correlate with the good clinical results; the interpretation of postoperative imaging remains therefore challenging.

Entities:  

Keywords:  AMIC; MOCART; collagen I/III matrix; osteochondral lesion; talus

Year:  2019        PMID: 31084491     DOI: 10.1177/0363546519841574

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  18 in total

Review 1.  Osteochondral lesions of the talar dome: an up-to-date approach to multimodality imaging and surgical techniques.

Authors:  Júlio Brandão Guimarães; Isabela Azevedo Nicodemos da Cruz; Caio Nery; Flávio Duarte Silva; Alípio Gomes Ormond Filho; Bruno Cerretti Carneiro; Marcelo Astolfi Caetano Nico
Journal:  Skeletal Radiol       Date:  2021-06-15       Impact factor: 2.199

2.  Influence of the Medial Malleolus Osteotomy on the Clinical Outcome of M-BMS + I/III Collagen Scaffold in Medial Talar Osteochondral Lesion (German Cartilage Register/Knorpelregister DGOU).

Authors:  Oliver Gottschalk; Sebastian Felix Baumbach; Sebastian Altenberger; Daniel Körner; Matthias Aurich; Christian Plaass; Sarah Ettinger; Daniel Guenther; Christoph Becher; Hubert Hörterer; Markus Walther
Journal:  Cartilage       Date:  2020-10-08       Impact factor: 3.117

3.  The Role of Magnetic Resonance Imaging in Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus: Analyzing MOCART 1 and 2.0.

Authors:  Fabio A Casari; Christoph Germann; Lizzy Weigelt; Stephan Wirth; Arnd Viehöfer; Jakob Ackermann
Journal:  Cartilage       Date:  2020-08-01       Impact factor: 3.117

4.  Autologous Matrix-Induced Chondrogenesis With Lateral Ligament Stabilization for Osteochondral Lesions of the Talus in Patients With Ankle Instability.

Authors:  Jakob Ackermann; Fabio A Casari; Christoph Germann; Lizzy Weigelt; Stephan H Wirth; Arnd F Viehöfer
Journal:  Orthop J Sports Med       Date:  2021-05-14

Review 5.  Osteochondral Lesions of the Talus: A Review on Talus Osteochondral Injuries, Including Osteochondritis Dissecans.

Authors:  Juergen Bruns; Christian Habermann; Mathias Werner
Journal:  Cartilage       Date:  2021-01-09       Impact factor: 3.117

6.  Smoking Is Associated with Anterior Ankle Impingement After Isolated Autologous Matrix-Induced Chondrogenesis for Osteochondral Lesions of the Talus.

Authors:  Arnd F Viehöfer; Fabio Casari; Felix W A Waibel; Silvan Beeler; Florian B Imhoff; Stephan H Wirth; Jakob Ackermann
Journal:  Cartilage       Date:  2020-09-17       Impact factor: 3.117

7.  Autologous matrix-induced chondrogenesis for the treatment of osteochondral lesions of the talus: A systematic review.

Authors:  Michael-Alexander Malahias; Lazaros Kostretzis; Panayiotis D Megaloikonomos; Erwin-Brian Cantiller; Dimitrios Chytas; Hajo Thermann; Christoph Becher
Journal:  Orthop Rev (Pavia)       Date:  2021-01-29

8.  AMIC for Focal Osteochondral Defect of the Talar Shoulder.

Authors:  Christian Götze; Christian Nieder; Hanna Felder; Filippo Migliorini
Journal:  Life (Basel)       Date:  2020-12-05

9.  Arthroscopic microfracture with atelocollagen augmentation for osteochondral lesion of the talus: a multicenter randomized controlled trial.

Authors:  Young Koo Lee; Ki Won Young; Jin Su Kim; Hong Seop Lee; Whi-Je Cho; Hyong Nyun Kim
Journal:  BMC Musculoskelet Disord       Date:  2020-11-03       Impact factor: 2.362

10.  Autologous Matrix Induced Chondrogenesis (AMIC) Compared to Microfractures for Chondral Defects of the Talar Shoulder: A Five-Year Follow-Up Prospective Cohort Study.

Authors:  Filippo Migliorini; Jörg Eschweiler; Nicola Maffulli; Hanno Schenker; Arne Driessen; Björn Rath; Markus Tingart
Journal:  Life (Basel)       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.